PAG, CX Partners and Samara Capital completed the acquisition of Optimus Drugs.

Investment companies PAG, CX Partners and Samara Capital completed the acquisition of Optimus Drugs, a Hyderabad, India-based pharmaceutical firm. Financial terms were not disclosed. "We are very pleased to be partnering with Dr. Reddy, Optimus Drugs and its employees to help them become one of the leading API players globally. Optimus is a clear leader in R&D, manufacturing, and intellectual property management. We’re looking forward to continuing their mission to deliver high quality, affordable health products across the globe," Nikhil Srivastava, PAG Partner and Managing Director, Head of India Private Equity.